Ajanta Pharmaceuticals Q3 Results

  • BSE: 532331
  • NSE: AJANTPHARM
  • ISIN: INE031B01049
  • Sector: Biotechnology & Drugs
BSE
2,422.424.15 (1.01%)
Volume2.31 K
Updated: Fri 24 May, 2024 | 15:29:07
NSE
2,422.6520.60 (0.86%)
Volume65.03 K
Updated: Fri 24 May, 2024 | 15:32:25
Today: 2,396.00
2,427.95
52-Wk: 1,254.05
2,531.95

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Ajanta Pharmaceuticals Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ Comp
    Total Revenue 1,105.151,028.447.46%
    Selling/ General/ Admin Expenses Total 231.35222.274.09%
    Depreciation/ Amortization 34.2633.711.63%
    Other Operating Expenses Total 257.98259.39-0.54%
    Total Operating Expense 817.76771.496.00%
    Operating Income 287.39256.9511.85%
    Net Income Before Taxes 290.91275.945.43%
    Net Income 210.03195.307.54%
    Diluted Normalized EPS 16.6715.507.55%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumFor youGet App